1,18 €
7,82 % gestern
L&S, 12. Juli, 22:52 Uhr
ISIN
US68404V1008
Symbol
OPTN
Berichte

OptiNose, Inc. Aktie News

Positiv
InvestorPlace
11 Tage alt
The stock market rally has been showing no sign of stopping, and while most of it has been driven by Big Tech, it is worth looking into some little-known penny stocks. These stocks usually see huge breakouts and trade at big premiums during bullish rallies.
Neutral
GlobeNewsWire
16 Tage alt
YARDLEY, Pa., June 27, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that XHANCE® (fluticasone propionate) has been added to Express Scripts' national formularies, including the National Preferred, Flex, and Basic formularies, among the largest commercial formularies in...
Neutral
Seeking Alpha
etwa 2 Monate alt
OptiNose, Inc. (NASDAQ:OPTN ) Q1 2024 Results Conference Call May 15, 2024 10:00 AM ET Company Participants Jonathan Neely - VP, IR & Business Development Dr. Ramy Mahmoud - CEO Conference Call Participants Thomas Flaten - Lake Street Capital Markets Schuyler van den Broek - Piper Sandler Glen Santangelo - Jefferies Matthew Caufield - H.C. Wainwright Operator Good day, and thank you for standin...
Neutral
GlobeNewsWire
etwa 2 Monate alt
YARDLEY, Pa., May 17, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ on May 20, 2024 at 11:30 a.m. ET.
Neutral
GlobeNewsWire
etwa 2 Monate alt
Company reports Q1 2024 XHANCE net revenue of $14.9 million, an increase of 26% compared to Q1 2023 Company expects full year 2024 XHANCE net revenues to be between $85.0 to $95.0 million Company expects peak year XHANCE net revenues of at least $300 million from current specialist focused prescriber audience Company expects to produce positive income from operations (GAAP) for full year 2025 C...
Neutral
GlobeNewsWire
2 Monate alt
Conference Call and Webcast to be held May 14, 2024, at 10:00 a.m. Eastern Time Conference Call and Webcast to be held May 14, 2024, at 10:00 a.m. Eastern Time
Negativ
InvestorPlace
3 Monate alt
Stocks are down today and investors wondering why have come to the right place as we have all the details behind the market slump on Thursday! The first bit of news that is pulling stocks down today comes from Meta Platforms (NASDAQ: META ).
Positiv
InvestorPlace
3 Monate alt
OptiNose (NASDAQ: OPTN ) stock is taking off on Thursday after the company provided investors with an update on XHANCE following an expansion of its use by the Food and Drug Administration (FDA). The expansion news includes the FDA signing off on XHANCE being used as a treatment for adult patients with chronic rhinosinusitis without nasal polyps.

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen